FDA Conditionally Approves XTENT's Stent System

The Food and Drug Administration conditionally approved XTENT Inc.'s (Nasdaq: XTNT) application to begin clinical trials for its drug eluting stent system. Shares of the medical device company surged 40 cents to $1.90.


About this Entry

This page contains a single entry by published on June 5, 2009 10:30 AM.

Western Refining Expands Stock Offering was the previous entry in this blog.

Helix To Sell 20 Million Shares Of Cal Dive is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.

Powered by Movable Type 5.12